Advanced search
Publication Cover
Annals of Medicine Volume 55, 2023 - Issue 2
Submit an article Journal homepage
491
Views
0
CrossRef citations to date
0
Altmetric
Pharmacology

The clinical characteristics and outcomes of different inhaled therapies in chronic obstructive pulmonary disease patients with frequent cough

Xueshan Lia Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Qing Songa Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Wei Chenga Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaORCID Iconhttps://orcid.org/0000-0003-1025-0591View further author information
ORCID Icon,
Cong Liua Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Ling Lina Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Jing Lia Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Yating Penga Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Yuqin Zenga Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Rong Yie Department of Pulmonary and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, Hunan, ChinaView further author information
,
Yi Liue Department of Pulmonary and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, Hunan, ChinaView further author information
,
Xin Lif Division 4 of Occupational Diseases, Hunan Prevention and Treatment Institute for Occupational Disease, Changsha, Hunan, ChinaView further author information
,
Yan Chena Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
,
Shan Caia Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaView further author information
&
Ping Chena Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;b Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China;c Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, China;d Clinical Medical Research Center for Respiratory and Critical Care Medicine in Hunan Province, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6707-8636View further author information
ORCID Icon show all
Article: 2304107 | Received 11 May 2023, Accepted 18 Dec 2023, Published online: 17 Jan 2024

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2023 Report). 2022.
  • Cho SH, Lin HC, Ghoshal AG, et al. Respiratory disease in the Asia-Pacific region: cough as a key symptom. Allergy Asthma Proc. 2016;37(2):1–10. doi: 10.2500/aap.2016.37.3925.
  • Crooks MG, Brown T, Morice AH. Is cough important in acute exacerbations of COPD? Respir Physiol Neurobiol. 2018;257:30–35. doi: 10.1016/j.resp.2018.02.005.
  • Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272. doi: 10.1183/09031936.00051110.
  • Deslee G, Burgel P-R, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2091–2097. doi: 10.2147/COPD.S106883.
  • Landt E, Çolak Y, Lange P, et al. Chronic cough in individuals with COPD: a Population-Based cohort study. Chest. 2020;157(6):1446–1454. doi: 10.1016/j.chest.2019.12.038.
  • Koo HK, Park SW, Park JW, et al. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:1793–1801. doi: 10.2147/COPD.S153821.
  • Lahousse L, Seys LJM, Joos GF, et al. Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease. Eur Respir J. 2017;50(2):1602470. doi: 10.1183/13993003.02470-2016.
  • Choate R, Pasquale CB, Parada NA, et al. The burden of cough and phlegm in people with COPD: a COPD patient-powered research network study. Chronic Obstr Pulm Dis. 2020;7(1):49–59. doi: 10.15326/jcopdf.7.1.2019.0146.
  • Choi JY, Yoon HK, Lee SY, et al. Comparison of clinical characteristics between chronic bronchitis and non-chronic bronchitis in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2022;22(1):69. doi: 10.1186/s12890-022-01854-x.
  • McGarvey L, Morice AH, Smith JA, et al. Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respir Res. 2016;3(1):e000148. doi: 10.1136/bmjresp-2016-000148.
  • Tagaya E, Yagi O, Sato A, et al. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther. 2016;39:81–84. doi: 10.1016/j.pupt.2016.06.008.
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi: 10.1183/09031936.00102509.
  • Liu C, Cheng W, Zeng Y, et al. Different characteristics of ex-smokers and current smokers with COPD: a cross-sectional study in China. Int J Chron Obstruct Pulmon Dis. 2020;15:1613–1619. doi: 10.2147/COPD.S255028.
  • Duan JX, Cheng W, Zeng YQ, et al. Characteristics of patients with chronic obstructive pulmonary disease exposed to different environmental risk factors: a large cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2020;15:2857–2867. doi: 10.2147/COPD.S267114.
  • Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54(3):1900561. doi: 10.1183/13993003.00561-2019.
  • Kon SSC, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi: 10.1016/S2213-2600(14)70001-3.
  • de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J. 2012;40(1):28–36. doi: 10.1183/09031936.00141611.
  • Benedetto U, Head SJ, Angelini GD, et al. Statistical primer: propensity score matching and its alternatives. †Eur J Cardiothorac Surg. 2018;53(6):1112–1117. doi: 10.1093/ejcts/ezy167.
  • Houben-Wilke S, Janssen DJA, Franssen FME, et al. Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores. Health Qual Life Outcomes. 2018;16(1):205. doi: 10.1186/s12955-018-1034-4.
  • Hughes R, Rapsomaniki E, Janson C, et al. Frequent productive cough: symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study. Respir Med. 2022;200:106921. doi: 10.1016/j.rmed.2022.106921.
  • Lee SD, Huang MS, Kang J, et al. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108(4):600–608. doi: 10.1016/j.rmed.2013.12.014.
  • Horita N, Goto A, Shibata Y, et al. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2017;2(2):CD012066.
  • Lee SD, Xie CM, Yunus F, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: a randomized, multicentre study in East Asia. Respirology. 2016;21(1):119–127. doi: 10.1111/resp.12646.
  • Maltais F, Bjermer L, Kerwin EM, et al. Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial. Respir Res. 2019;20(1):238. doi: 10.1186/s12931-019-1193-9.
  • Singh D, Fabbri LM, Vezzoli S, et al. Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. Int J Chron Obstruct Pulmon Dis. 2019;14:531–546. doi: 10.2147/COPD.S196383.
  • Zheng J, Baldi S, Zhao L, et al. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in Eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial. Respir Res. 2021;22(1):90. doi: 10.1186/s12931-021-01683-2.
  • Cheng W, Duan JX, Zhou AY, et al. Real-world effectiveness of inhalation therapy among patients with symptomatic COPD in China: a multicenter prospective study. Front Pharmacol. 2021;12:753653. doi: 10.3389/fphar.2021.753653.
  • Vestbo J, Papi A, Corradi M, et al. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (Trinity): a double-blind, parallel group, randomised controlled trial. Lancet. 2017;389(10082):1919–1929. doi: 10.1016/S0140-6736(17)30188-5.
  • Wang MT, Lai JH, Huang YL, et al. Comparative effectiveness and safety of different types of inhaled long-acting beta(2)-agonist plus inhaled long-acting muscarinic antagonist vs inhaled long-acting beta(2)-agonist plus inhaled corticosteroid fixed-dose combinations in COPD a propensity score-inverse probability of treatment weighting cohort study. Chest. 2021;160(4):1255–1270. doi: 10.1016/j.chest.2021.05.025.
  • Wang C, Yang T, Kang J, et al. Efficacy and safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in Chinese patients with COPD: a subgroup analysis of KRONOS. Adv Ther. 2020;37(4):1591–1607. doi: 10.1007/s12325-020-01266-5.
  • Lin L, Song Q, Cheng W, et al. Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease. Ann Med. 2022;54(1):875–885. doi: 10.1080/07853890.2022.2055134.
  • Rebelo P, Oliveira A, Paixão C, et al. Minimal clinically important differences for Patient-Reported outcome measures of cough and sputum in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:201–212. doi: 10.2147/COPD.S219480.
  • Patalano F, Hache C, Pethe A, et al. Performance of the cough and sputum assessment questionnaire (CASA-Q) in COPD: evidence from clinical and online patient interaction studies. Int J Chron Obstruct Pulmon Dis. 2022;17:3087–3096. doi: 10.2147/COPD.S381131.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.